Benefits: The results of this work may help to lower the incidence of this ocular disease in
Appaloosas and other breeds, help breeders to
make informed mating decisions, and be utilized by veterinarians to predict risk of developing disease for earlier diagnosis and treatment.
We can not promise any benefits to your horse or other animals from your taking part in this clinical trial; however, possible benefits include lowering the incidence of this common eye cancer in Haflinger, Belgian, Percheron,
Appaloosa, and Arabian Horses, helping breeders to
make informed mating decisions, and better prediction of the risk of developing disease for earlier diagnosis and treatment.